IMPACT OF CORONARY ANATOMICAL COMPLEXITY ON THE EFFECT OF EXTENDED DURATION DUAL ANTIPLATELET THERAPY: AN ANALYSIS FROM THE DUAL ANTIPLATELET THERAPY STUDY

被引:1
|
作者
Yeh, Robert W.
Kereiakes, Dean
Steg, Philippe
Cutlip, Donald
Croce, Kevin
Apruzzese, Patricia
Massaro, Joseph
Mauri, Laura
机构
[1] Harvard Clin Res Inst, Boston, MA USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
关键词
D O I
10.1016/S0735-1097(17)34400-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1113-131
引用
收藏
页码:1011 / 1011
页数:1
相关论文
共 50 条
  • [1] Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease A Subanalysis of the Dual Antiplatelet Therapy Study
    Secemsky, Eric A.
    Yeh, Robert W.
    Kereiakes, Dean J.
    Cutlip, Donald E.
    Steg, P. Gabriel
    Massaro, Joseph M.
    Apruzzese, Patricia K.
    Mauri, Laura
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (09) : 942 - 954
  • [2] Duration of dual antiplatelet therapy in acute coronary syndrome
    Wilson, Simon John
    Newby, David E.
    Dawson, Dana
    Irving, John
    Berry, Colin
    [J]. HEART, 2017, 103 (08) : 573 - 580
  • [3] Duration of dual antiplatelet therapy after coronary stenting
    Briasoulis, Alexandros
    Palla, Mohan
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 222 : 1064 - 1067
  • [4] Dual Antiplatelet Therapy Duration Following Coronary Stenting
    Yeh, Robert W.
    Mauri, Laura
    Kereiakes, Dean J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (08) : 787 - 790
  • [5] Duration of Dual Antiplatelet Therapy After Coronary Stenting
    Siasos, Gerasimos
    Mourouzis, Konstantinos
    Oikonomou, Evangelos
    Vavuranakis, Manolis
    Vogiatzi, Georgia
    Briasoulis, Alexandros
    Papageorgiou, Nikolaos
    Papaioannou, Theodore G.
    Zografos, Thodoris
    Papapanagiotou, Angeliki
    Papavassiliou, Athanasios G.
    Stefanadis, Christodoulos
    Tousoulis, Dimitris
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (29) : 4583 - 4595
  • [6] Optimal duration of dual antiplatelet therapy
    Fakiolas, Constantine
    [J]. SCIENTIFIC CHRONICLES, 2013, 18 (02) : 73 - 75
  • [7] Interruption of Dual Antiplatelet Therapy Within Six Months After Coronary Stents (from the Dual Antiplatelet Therapy Study)
    Schmidt, Ada C. Stefanescu
    Steg, Philippe Gabriel
    Yeh, Robert W.
    Kereiakes, Dean J.
    Tanguay, Jean -Francois
    Hsieh, Wen-Hua
    Massaro, Joseph M.
    Mauri, Laura
    Cutlip, Donald E.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2019, 124 (12): : 1813 - 1820
  • [8] INDIVIDUALIZING DURATION OF DUAL ANTIPLATELET THERAPY BASED ON BLEEDING RISK, ISCHEMIC RISK, OR BOTH: AN ANALYSIS FROM THE DUAL ANTIPLATELET THERAPY (DAPT) STUDY
    Mihatov, Nino
    Secemsky, Eric
    Kereiakes, Dean
    Steg, Philippe Gabriel
    Cutlip, Donald
    Kirtane, Ajay
    Mehran, Roxana
    Zhao, Bokai
    Song, Yang
    Gibson, C. Michael
    Yeh, Robert
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 952 - 952
  • [9] Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
    Yeh, Robert W.
    Kereiakes, Dean J.
    Steg, P. Gabriel
    Cutlip, Donald E.
    Croce, Kevin J.
    Massaro, Joseph M.
    Mauri, Laura
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : 2213 - 2223
  • [10] Optimal duration of dual antiplatelet therapy for coronary artery disease
    Kikkert, W. J.
    Damman, P.
    [J]. NETHERLANDS HEART JOURNAL, 2018, 26 (06) : 321 - 333